Literature DB >> 15284016

In vitro neuromuscular activity of 'colubrid' venoms: clinical and evolutionary implications.

Natalie G Lumsden1, Bryan G Fry, R Manjunatha Kini, Wayne C Hodgson.   

Abstract

In this study, venoms from species in the Colubrinae, Homalopsinae, Natricinae, Pseudoxyrhophiinae and Psammophiinae snake families were assayed for activity in the chick biventer cervicis skeletal nerve muscle preparation. Boiga dendrophila, Boiga cynodon, Boiga dendrophila gemincincta, Boiga drapiezii, Boiga irregularis, Boiga nigriceps and Telescopus dhara venoms (10 microg/ml) displayed postsynaptic neuromuscular activity as evidenced by inhibition of indirect (0.1 Hz, 0.2 ms, supramaximal V) twitches. Neostigmine (5 microM) reversed the inhibition caused by B. cynodon venom (10 microg/ml) while the inhibitory effects of Psammophis mossambicus venom (10 microg/ml) spontaneously reversed, indicating a reversible mode of action for both venoms. Trimorphodon biscutatus (10 microg/ml) displayed irreversible presynaptic neurotoxic activity. Detectable levels of phospholipase A2 activity were found only in T. biscutatus, T. dhara and P. mossambicus venoms. The results demonstrate a hitherto unsuspected diversity of pharmacological actions in all lineages which may have implications ranging from clinical management of envenomings to venom evolution.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15284016     DOI: 10.1016/j.toxicon.2004.03.012

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  7 in total

Review 1.  Anticoagulant proteins from snake venoms: structure, function and mechanism.

Authors:  R Manjunatha Kini
Journal:  Biochem J       Date:  2006-08-01       Impact factor: 3.857

2.  The Bold and the Beautiful: a Neurotoxicity Comparison of New World Coral Snakes in the Micruroides and Micrurus Genera and Relative Neutralization by Antivenom.

Authors:  Daryl C Yang; James Dobson; Chip Cochran; Daniel Dashevsky; Kevin Arbuckle; Melisa Benard; Leslie Boyer; Alejandro Alagón; Iwan Hendrikx; Wayne C Hodgson; Bryan G Fry
Journal:  Neurotox Res       Date:  2017-07-03       Impact factor: 3.911

3.  Three-Finger Toxin Diversification in the Venoms of Cat-Eye Snakes (Colubridae: Boiga).

Authors:  Daniel Dashevsky; Jordan Debono; Darin Rokyta; Amanda Nouwens; Peter Josh; Bryan G Fry
Journal:  J Mol Evol       Date:  2018-09-12       Impact factor: 2.395

4.  Three-fingered RAVERs: Rapid Accumulation of Variations in Exposed Residues of snake venom toxins.

Authors:  Kartik Sunagar; Timothy N W Jackson; Eivind A B Undheim; Syed A Ali; Agostinho Antunes; Bryan G Fry
Journal:  Toxins (Basel)       Date:  2013-11-18       Impact factor: 4.546

5.  The Snake with the Scorpion's Sting: Novel Three-Finger Toxin Sodium Channel Activators from the Venom of the Long-Glanded Blue Coral Snake (Calliophis bivirgatus).

Authors:  Daryl C Yang; Jennifer R Deuis; Daniel Dashevsky; James Dobson; Timothy N W Jackson; Andreas Brust; Bing Xie; Ivan Koludarov; Jordan Debono; Iwan Hendrikx; Wayne C Hodgson; Peter Josh; Amanda Nouwens; Gregory J Baillie; Timothy J C Bruxner; Paul F Alewood; Kelvin Kok Peng Lim; Nathaniel Frank; Irina Vetter; Bryan G Fry
Journal:  Toxins (Basel)       Date:  2016-10-18       Impact factor: 4.546

6.  The Dragon's Paralysing Spell: Evidence of Sodium and Calcium Ion Channel Binding Neurotoxins in Helodermatid and Varanid Lizard Venoms.

Authors:  James S Dobson; Richard J Harris; Christina N Zdenek; Tam Huynh; Wayne C Hodgson; Frank Bosmans; Rudy Fourmy; Aude Violette; Bryan G Fry
Journal:  Toxins (Basel)       Date:  2021-08-06       Impact factor: 4.546

7.  A Taxon-Specific and High-Throughput Method for Measuring Ligand Binding to Nicotinic Acetylcholine Receptors.

Authors:  Christina N Zdenek; Richard J Harris; Sanjaya Kuruppu; Nicholas J Youngman; James S Dobson; Jordan Debono; Muzaffar Khan; Ian Smith; Mike Yarski; David Harrich; Charlotte Sweeney; Nathan Dunstan; Luke Allen; Bryan G Fry
Journal:  Toxins (Basel)       Date:  2019-10-16       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.